Business Description
MultiCell Technologies Inc
NAICS : 325412
SIC : 2834
ISIN : US62544S2005
Description
MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -24.47 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MCET
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MultiCell Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.805 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | -54.47 | ||
| Volatility % | 90 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000006 | ||
| 20-Day SMA ($) | 0.000078 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.00001 - 0.0001 | ||
| Shares Outstanding (Mil) | 5,000.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MultiCell Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MultiCell Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MultiCell Technologies Inc Frequently Asked Questions
What is MultiCell Technologies Inc(MCET)'s stock price today?
The current price of MCET is $0.00. The 52 week high of MCET is $0.00 and 52 week low is $0.00.
When is next earnings date of MultiCell Technologies Inc(MCET)?
The next earnings date of MultiCell Technologies Inc(MCET) is 0.
Does MultiCell Technologies Inc(MCET) pay dividends? If so, how much?
MultiCell Technologies Inc(MCET) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers